A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Systemic Lupus Erythematosus
Related studies linked through entity extraction aliases.
SII and SIRI as Prognostic Biomarkers in Lupus Nephritis
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study to Test CRT-402 in Refractory Autoimmune Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of QLS2404 Injection in Healthy Participants and Participants With Rheumatic Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
SNC116 Therapy for Refractory Systemic Lupus Erythematosus
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study to Characterise Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Anifrolumab Administered Subcutaneously (SC) or Intravenously (IV)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Dapagliflozin to Reduce the Decline in Renal Function in Patients Newly Diagnosed With Lupus Nephritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Biomarker Development for Autoimmune Disorders Involving the Kidneys
- Status
- RECRUITING
- Phase
- N/A
Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Reduced Vaccine Response to HZ/su in SLE
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA)
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE2
Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
- Status
- RECRUITING
- Phase
- NA
MTS109 in Patients With Refractory Autoimmune Diseases
- Status
- RECRUITING
- Phase
- EARLY_PHASE1